Filing Details

Accession Number:
0001140361-14-042696
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-18 17:12:24
Reporting Period:
2014-11-14
Filing Date:
2014-11-18
Accepted Time:
2014-11-18 17:12:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1260990 Gtx Inc GTXI Pharmaceutical Preparations (2834) 621715807
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1602393 Foundation Peak Pyramid 6410 Poplar Avenue
Suite 710
Memphis TN 38119
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-14 24,545,455 $0.00 30,533,479 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrants (right to buy) Acquisiton 2014-11-14 24,545,455 $0.00 24,545,455 $0.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
24,545,455 No 4 P Direct
Footnotes
  1. The reported securities are included within 24,545,455 immediately separable Units purchased by the reporting person for $0.675 per Unit. Each Unit consists of one share of Common Stock and one warrant to purchase one share of Common Stock.
  2. The warrants will be exercisable at any time and from time to time from and after the earlier of (i) the Stockholder Approval Date (as defined below) or (ii) the trading day immediately prior to the occurrence of a "fundamental transaction" (as such term is defined in the warrants, which are attached to Exhibit 10.1 of the Current Report on Form 8-K of the Issuer filed with the Securities and Exchange Commission on November 10, 2014), but in no event later than June 1, 2015, and would continue to be exercisable for four years thereafter. The Stockholder Approval Date means the date the Issuer receives stockholder approval, at a special or annual meeting to be held no later than May 27, 2015, of an amendment to the Issuer's Certificate of Incorporation to increase the Issuer's authorized Common Stock to an amount necessary to effect the share settlement of all of the warrants issued by the Issuer on November 14, 2014.